PreprintCited by 18CAR-T cell therapy researchT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells

Open access
Weber, Evan W., Lynn, Rachel C., Parker, Kevin R., Anbunathan, Hima, Lattin, John, Sotillo, Elena, Good, Zinaida, Malipatlolla, Meena +10 more·2020·bioRxiv (Cold Spring Harbor Laboratory)

Abstract

SUMMARY: T cell exhaustion limits immune responses against cancer and is a major cause of resistance to CAR-T cell therapeutics. Using a model wherein tonic CAR signaling induces hallmark features of exhaustion, we employed a drug-regulatable CAR to test the impact of transient cessation of receptor signaling (i.e. “rest”) on the development and maintenance of exhaustion. Induction of rest in exhausting or already-exhausted CAR-T cells resulted in acquisition of a memory-like phenotype, improved anti-tumor functionality, and wholescale transcriptional and epigenetic reprogramming. Similar results were achieved with the Src kinase inhibitor dasatinib, which reversibly suppresses CAR signaling. The degree of functional reinvigoration was proportional to the duration of rest and was associated with expression of transcription factors TCF1 and LEF1. This work demonstrates that transient cessation of CAR-T cell signaling can enhance anti-tumor potency by preventing or reversing exhaustion and challenges the paradigm that exhaustion is an epigenetically fixed state.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.01.26.920496

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A thalidomide analogue-inducible dimerization domain has been generated from a fragment of CRBN and a zinc finger with all lysines substituted to arginines (K0), and split CARs have been built that require drug treatment for dimerization and subsequent activation.

    “Furthermore, a thalidomide analogue-inducible dimerization domain has been generated from a fragment of CRBN and a zinc finger with all lysines substituted to arginines (K0), and with this system split CARs have been built that require drug treatment for dimerization and subsequent activation207.”
  • 'Super-degron' tags composed of hybrid zinc finger degrons have been engineered to enhance the efficiency of drug-mediated degradation.

    “To further develop this concept, ‘super-degron’ tags composed of hybrid zinc finger degrons have been engineered to enhance the efficiency of drug-mediated degradation117,207.”
  • Super-degron tags have been incorporated into thalidomide analogue-mediated off-switch CARs, which can be degraded and functionally inhibited at sub-therapeutic drug concentrations.

    “These super-degron tags have been incorporated into thalidomide analogue-mediated off-switch CARs, which can be degraded and thus functionally inhibited at sub-therapeutic drug concentrations (FIG. 4)207.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Weber, E. W., Lynn, R. C., Parker, K. R., Anbunathan, H., Lattin, J., Sotillo, E., Good, Z., Malipatlolla, M., Xu, P., Vandris, P., Majzner, R. G., Qi, Y., Chen, L.-C., Gentles, A. J., Wandless, T. J., Satpathy, A. T., Chang, H. Y., & Mackall, C. L.
Affiliations
  • Stanford Medicine (US)
  • Parker Institute for Cancer Immunotherapy (US)
  • Stanford University (US)
Corresponding author
Mackall, Crystal L.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2020-01-27
OpenAlex
W3003116639
Cited by
18
References
92
Citations by year
2025: 1 · 2022: 2 · 2021: 9 · 2020: 6
Type
posted content
Language
en
Open access
Locations
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
Funders
  • Howard Hughes Medical Institute
  • Parker Institute for Cancer Immunotherapy
  • Human Vaccines Project
  • National Institutes of Health (AI 07290)
  • Stand Up To Cancer (SU2CAACR-DT1113)
  • National Cancer Institute (K08CA230188, SU2CAACR-DT1113, U54CA232568)
  • National Institute of Allergy and Infectious Diseases (AI 07290, T32AI007290)
Topics
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
T cell exhaustion, chimeric antigen receptor T cells, epigenetic remodeling, dasatinib, Src kinase inhibition, TCF1, LEF1, antitumor immunity, transcriptional reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review